Related Experiment Video
Updated: Jun 1, 2025

07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
9.5K
Advances in Radiation Oncology in Soft Tissue Sarcoma
Sara B Leier1, Safia K Ahmed2,3
1Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Current Oncology Reports
|January 21, 2025
Summary
Recent advances in radiation therapy (RT) for soft tissue sarcomas (STS) show hypofractionated preoperative RT is safe and effective. Further research is ongoing for unresectable STS and advanced applications like particle therapy.
Area of Science:
- Oncology
- Radiation Oncology
Background:
- Soft tissue sarcomas (STS) are a diverse group of malignant tumors.
- Effective treatment of STS often requires a multidisciplinary approach, including radiation therapy (RT).
Purpose of the Study:
- To review recent advancements in radiation therapy (RT) for soft tissue sarcomas (STS).
Main Methods:
- Review of current literature and recent data on RT for STS.
- Analysis of hypofractionated preoperative RT, dose-escalated RT, and particle therapy.
Main Results:
- Hypofractionated preoperative RT demonstrates safety and efficacy in surgically treated STS patients, pending long-term data.
- Hypofractionated and dose-escalated RT for unresectable STS show promise with advanced planning.
- Selective use of stereotactic fractionated radiation therapy (SFRT) may enhance tumor control.
- Particle therapy offers potential benefits for high-dose RT near critical structures, re-irradiation, and reducing secondary malignancy risk.
Conclusions:
- Recent RT advances offer improved outcomes for both localized and advanced STS.
- Ongoing research and novel RT techniques like particle therapy are expanding treatment options for STS patients.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K

